Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
The Royal Wolverhampton Hospitals NHS Trust
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Lahore General Hospital
NHS Lothian
N.N. Alexandrov National Cancer Centre
Azienda USL Reggio Emilia - IRCCS
Turku University Hospital
Ankara Etlik City Hospital
VƤsternorrland County Council, Sweden
National Cancer Center, Korea
Sykehuset Telemark
East and North Hertfordshire NHS Trust
Linkoeping University
Ministry of Science and Technology of the People“s Republic of China
Turku University Hospital
University Hospital, Angers
Sanpasitthiprasong Hospital
Hull University Teaching Hospitals NHS Trust
Anhui Provincial Hospital
Turku University Hospital
Slovak Academy of Sciences
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Mersin Training and Research Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Azienda USL Reggio Emilia - IRCCS
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Gulhane Training and Research Hospital
Turku University Hospital
Turku University Hospital
Turku University Hospital
Turku University Hospital
Assaf-Harofeh Medical Center
University Hospital, Angers
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
Sheba Medical Center
Hull University Teaching Hospitals NHS Trust
Ziv Hospital
Turku University Hospital
Turku University Hospital
Turku University Hospital
Turku University Hospital
National Cancer Center, Korea
University Hospital, Angers
Vancouver Coastal Health
Turku University Hospital
Sheba Medical Center
Turku University Hospital